| Literature DB >> 33357426 |
Kyoko Ochiai1, Mari Yamaoka2, Amrutha Swaminathan3, Hiroki Shima2, Hitoshi Hiura4, Mitsuyo Matsumoto5, Daisuke Kurotaki6, Jun Nakabayashi7, Ryo Funayama8, Keiko Nakayama8, Takahiro Arima4, Tomokatsu Ikawa9, Tomohiko Tamura10, Roger Sciammas11, Philippe Bouvet12, Tapas K Kundu13, Kazuhiko Igarashi14.
Abstract
The chromatin protein positive coactivator 4 (PC4) has multiple functions, including chromatin compaction. However, its role in immune cells is largely unknown. We show that PC4 orchestrates chromatin structure and gene expression in mature B cells. B-cell-specific PC4-deficient mice show impaired production of antibody upon antigen stimulation. The PC4 complex purified from B cells contains the transcription factors (TFs) IKAROS and IRF4. IKAROS protein is reduced in PC4-deficient mature B cells, resulting in de-repression of their target genes in part by diminished interactions with gene-silencing components. Upon activation, the amount of IRF4 protein is not increased in PC4-deficient B cells, resulting in reduction of plasma cells. Importantly, IRF4 reciprocally induces PC4 expression via a super-enhancer. PC4 knockdown in human B cell lymphoma and myeloma cells reduces IKAROS protein as an anticancer drug, lenalidomide. Our findings establish PC4 as a chromatin regulator of B cells and a possible therapeutic target adjoining IKAROS in B cell malignancies.Entities:
Keywords: IKAROS; IRF4; PC4; cell survival; chromatin; complex purification; human B cell malignancy; mature B cell; plasma cell differentiation
Mesh:
Substances:
Year: 2020 PMID: 33357426 DOI: 10.1016/j.celrep.2020.108517
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423